NCT00503217

Brief Summary

The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Feb 2005

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 18, 2007

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

September 7, 2016

Status Verified

September 1, 2016

Enrollment Period

2.8 years

First QC Date

July 17, 2007

Last Update Submit

September 5, 2016

Conditions

Intrauterine Insemination

Keywords

intrauterine inseminationGnRH agonistimplantation

Interventions

TryptorelinDRUG

Eligibility Criteria

Age18 Years - 38 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women \< 38 years old
  • Bilateral tubal patency confirmed by hysterosonography
  • Normal ultrasound scan of uterus and ovaries
  • Normal day 3 basal hormones
  • Motile sperm count after capacitation ≥ 3 mill/ml

You may not qualify if:

  • Endometriosis
  • Polycystic ovary syndrome
  • Uterine disease (polyps, myomas and müllerian diseases)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Valenciano de Infertilidad Spain

Valencia, Valencia, 46015, Spain

Location

Study Officials

  • Jose Bellver, MD

    Instituto Valenciano de la Infertilidad

    PRINCIPAL INVESTIGATOR

  • Elena Labarta, MD

    Instituto Valenciano de Infertilidad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gynecologist IVI Valencia

Study Record Dates

First Submitted

July 17, 2007

First Posted

July 18, 2007

Study Start

February 1, 2005

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

September 7, 2016

Record last verified: 2016-09

Locations

ES(1)